The enantioselective total synthesis of the antitumor macrolide natural product rhizoxin D

This publication has 27 references indexed in Scilit:

• Species Variation in Pharmacokinetics and Opsonization of Palmitoyl Rhizoxin (RS-1541) Incorporated in Lipid Emulsions
  Journal of Drug Targeting, 1998
• Inhibition of Angiogenesis by Rhizoxin, a Microbial Metabolite Containing Two Epoxide Groups
  Japanese Journal of Cancer Research, 1997
• Multicentre phase II pharmacological evaluation of rhizoxin
  British Journal of Cancer, 1996
• Pharmacokinetics of Highly Lipophilic Antitumor Agent Palmitoyl Rhizoxin Incorporated in Lipid Emulsions in Rats.
  Biological & Pharmaceutical Bulletin, 1996
• Intracellular activation and cytotoxic action of RS-1541 against cultured human tumor cells
  Cancer Chemotherapy and Pharmacology, 1995
• Tumor Selective Effect of RS-1541 (Palmitoyl-Rhizoxin) in M5076 Sarcoma and Host Tissues in Vivo
  Pharmaceutical Research, 1995
• Studies on macrocyclic lactone antibiotics. IX. Novel macrolides from the fungus Rhizopus chinensis: Precursors of rhizoxin.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1986
• A new antitumor complex, WF-1360, WF-1360A, B, C, D, E and F.
  The Journal of Antibiotics, 1986
• Studies on macrocyclic lactone antibiotics. VIII. Absolute structures of rhizoxin and a related compound.
  The Journal of Antibiotics, 1986
• Studies on macrocyclic lactone antibiotics. VII Structure of a phytotoxin "rhizoxin" produced by Rhizopus chinensis.
  The Journal of Antibiotics, 1984